© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Inari Medical, Inc. (NARI) stock remained unchanged at $79.97 a share on NASDAQ. The stock opened at $79.96, fluctuating between $79.96 to $79.97 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 18, 2025 | 79.97 | 79.99 | 79.96 | 79.97 | 2.36M |
| Feb 14, 2025 | 79.94 | 79.97 | 79.93 | 79.93 | 1.01M |
| Feb 13, 2025 | 79.91 | 79.95 | 79.91 | 79.93 | 745.6K |
| Feb 12, 2025 | 79.86 | 79.95 | 79.86 | 79.92 | 1.59M |
| Feb 11, 2025 | 79.88 | 79.92 | 79.85 | 79.88 | 1.39M |
| Feb 10, 2025 | 79.90 | 79.90 | 79.84 | 79.86 | 790.18K |
| Feb 07, 2025 | 79.87 | 79.90 | 79.76 | 79.76 | 1.08M |
| Feb 06, 2025 | 79.87 | 79.90 | 79.83 | 79.87 | 760.2K |
| Feb 05, 2025 | 79.87 | 79.93 | 79.83 | 79.89 | 1.16M |
| Feb 04, 2025 | 79.87 | 79.89 | 79.82 | 79.85 | 1.58M |
| Feb 03, 2025 | 79.69 | 79.75 | 79.60 | 79.62 | 958.85K |
| Jan 31, 2025 | 79.70 | 79.73 | 79.61 | 79.67 | 758.46K |
| Jan 30, 2025 | 79.76 | 79.76 | 79.60 | 79.69 | 1.43M |
| Jan 29, 2025 | 79.65 | 79.76 | 79.56 | 79.70 | 989.52K |
| Jan 28, 2025 | 79.60 | 79.66 | 79.55 | 79.60 | 785.21K |
| Jan 27, 2025 | 79.75 | 79.75 | 79.56 | 79.62 | 664.33K |
| Jan 24, 2025 | 79.54 | 79.76 | 79.47 | 79.74 | 1.66M |
| Jan 23, 2025 | 79.46 | 79.60 | 79.40 | 79.46 | 1.56M |
| Jan 22, 2025 | 79.53 | 79.66 | 79.42 | 79.42 | 2.33M |
| Jan 21, 2025 | 79.54 | 79.61 | 79.44 | 79.50 | 2.94M |
Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
| Employees | 1300 |
| Beta | 1.03 |
| Sales or Revenue | $493.63M |
| 5Y Sales Change% | 56.237% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |